451 related articles for article (PubMed ID: 30348117)
1. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
2. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia.
Ni J; Hong J; Li Q; Zeng Q; Xia R
Leuk Res; 2021 Jun; 105():106564. PubMed ID: 33857783
[TBL] [Abstract][Full Text] [Related]
4. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
6. miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.
Zou ZJ; Fan L; Wang L; Xu J; Zhang R; Tian T; Li JY; Xu W
Oncotarget; 2015 Jan; 6(2):1276-85. PubMed ID: 25361012
[TBL] [Abstract][Full Text] [Related]
7. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
[TBL] [Abstract][Full Text] [Related]
8. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
9. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
[TBL] [Abstract][Full Text] [Related]
12. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
[TBL] [Abstract][Full Text] [Related]
13. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
[TBL] [Abstract][Full Text] [Related]
14. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
16. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
17. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
[TBL] [Abstract][Full Text] [Related]
18. [Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].
Wang F; Xu W; Gu WY; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):34-39. PubMed ID: 32027250
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
Blume CJ; Hotz-Wagenblatt A; Hüllein J; Sellner L; Jethwa A; Stolz T; Slabicki M; Lee K; Sharathchandra A; Benner A; Dietrich S; Oakes CC; Dreger P; te Raa D; Kater AP; Jauch A; Merkel O; Oren M; Hielscher T; Zenz T
Leukemia; 2015 Oct; 29(10):2015-23. PubMed ID: 25971364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
